Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
Pediatric Studies Characteristics - Detail
FDA Home
Pediatrics
Pediatric Studies Characteristics
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Approval Date:
12/15/2011
Trade Name:
Nexium
Generic or Proper Name (*):
esomeprazole
Indications Studied:
Erosive esophagitis due to acid-mediated gastroesophageal reflux disease
Therapeutic Category:
Antiulcerative
Ages Studied:
0 - < 44 weeks
Study #:
3
Study Type:
Pharmacokinetic/Pharmacodynamic
Study Design:
Open Label/Traditional Pharmacokinetic
No Patients:
26
No Centers:
1
No Countries:
1
BPCA(B), PREA(P):
B, P
Unknown:
0
-
-